Genis   Report issue

For profit Phase 1
Founded: Siglufjord Iceland (2005)
Status: No NME R&D (2005)

Organization Overview

First Clinical Trial
2017
NCT03320525
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

GENIS

Active Ingredients

Drugs in Phase 1 Trials (1)

t-chos (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1